Home
Scholarly Works
Sibrafiban was not more efficacious than aspirin...
Journal article

Sibrafiban was not more efficacious than aspirin in preventing death and cardiovascular events in patients with acute coronary syndromes

Authors

Crowther MA

Journal

Evidence-based Cardiovascular Medicine, Vol. 4, No. 2,

Publisher

Elsevier

Publication Date

June 1, 2000

DOI

10.1054/ebcm.2000.0297

ISSN

1361-2611

Contact the Experts team